- Home
- ADAP vs CVGI Comparison
ADAP vs CVGI Comparison
Compare ADAP & CVGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CVGI
- Stock Information
- Founded
- ADAP 2008
- CVGI 2000
- Country
- ADAP United Kingdom
- CVGI United States
- Employees
- ADAP N/A
- CVGI N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CVGI Auto Parts:O.E.M.
- Sector
- ADAP Health Care
- CVGI Consumer Discretionary
- Exchange
- ADAP Nasdaq
- CVGI Nasdaq
- Market Cap
- ADAP 71.6M
- CVGI 71.8M
- IPO Year
- ADAP 2015
- CVGI 2004
- Fundamental
- Price
- ADAP $0.24
- CVGI $0.90
- Analyst Decision
- ADAP Strong Buy
- CVGI Buy
- Analyst Count
- ADAP 5
- CVGI 1
- Target Price
- ADAP $1.83
- CVGI $10.00
- AVG Volume (30 Days)
- ADAP 2.6M
- CVGI 433.5K
- Earning Date
- ADAP 05-14-2025
- CVGI 05-05-2025
- Dividend Yield
- ADAP N/A
- CVGI N/A
- EPS Growth
- ADAP N/A
- CVGI N/A
- EPS
- ADAP N/A
- CVGI N/A
- Revenue
- ADAP $178,032,000.00
- CVGI $723,355,000.00
- Revenue This Year
- ADAP N/A
- CVGI N/A
- Revenue Next Year
- ADAP $65.49
- CVGI $6.33
- P/E Ratio
- ADAP N/A
- CVGI N/A
- Revenue Growth
- ADAP 195.34
- CVGI N/A
- 52 Week Low
- ADAP $0.20
- CVGI $0.85
- 52 Week High
- ADAP $1.48
- CVGI $6.44
- Technical
- Relative Strength Index (RSI)
- ADAP 37.78
- CVGI 29.55
- Support Level
- ADAP $0.23
- CVGI $0.81
- Resistance Level
- ADAP $0.26
- CVGI $0.98
- Average True Range (ATR)
- ADAP 0.04
- CVGI 0.13
- MACD
- ADAP 0.01
- CVGI -0.00
- Stochastic Oscillator
- ADAP 31.85
- CVGI 18.00
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a supplier of cab-related products and systems. Its operating segments are Vehicle Solutions, Industrial Automation, Electrical Systems, and Aftermarket and Accessories. Vehicle Solutions segment designs manufacture and sell Commercial vehicle seats and Plastic components. Warehouse Automation segment designs, manufactures, and sells Warehouse automation subsystems including control panels, electro-mechanical assemblies, cable assemblies, and power and communication solutions. Electrical Systems segment designs, manufactures and sells cable and harness assemblies for both high and low voltage applications, control boxes, dashboard assemblies, and design and engineering for these applications. The company makes majority of its revenue from Vehicle Solutions.